What's in Faes Farma, S.A.'s pipeline?

Faes Farma, S.A. has 9 drugs in our index: 0 marketed, 0 filed, 2 in Phase 3, 4 in Phase 2, 2 in Phase 1.

Which companies overlap with Faes Farma, S.A.'s portfolio?

Top competitors by shared drug class: Allergan, Bausch & Lomb Incorporated, Erasmus Medical Center, Farmoquimica S.A., Genentech, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/faes-farma-s-a.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Faes Farma, S.A. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Faes Farma, S.A. pipeline: 0 marketed, 0 filed, 2 Phase 3, 4 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 2 Phase 3 4 Phase 2 2 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Bilastine Ophthalmic Solution 0.6%	Bilastine Ophthalmic Solution 0.6%	phase 3	Selective H1-receptor antagonist (antihistamine)	H1 histamine receptor	Ophthalmology / Allergy
Vehicle of Bilastine Ophthalmic Solution	Vehicle of Bilastine Ophthalmic Solution	phase 3	Selective H1-receptor antagonist (antihistamine)	H1 histamine receptor	Ophthalmology / Allergy

Therapeutic area mix

Allergy · 2
Ophthalmology / Allergy · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Allergan · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
Erasmus Medical Center · 1 shared drug class
Farmoquimica S.A. · 1 shared drug class
Genentech, Inc. · 1 shared drug class
Merck Sharp & Dohme LLC · 1 shared drug class
ORA, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Faes Farma, S.A.:

Cite this brief

Drug Landscape (2026). Faes Farma, S.A. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/faes-farma-s-a. Accessed 2026-06-10.